Adamis Pharmaceuticals Current Cash

As of the most recent data (September 2023), ADMP shows a current cash of $6.7B. That compares with $2.4M in the prior-year period — up 275273.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADMP's current cash is now $6.7B (was $2.4M) — a 275273.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Adamis Pharmaceuticals is outperforming or lagging.

Tracking ADMP's current cash over time shows whether Adamis Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $6.7B That compares with $2.4M in the prior-year period — up 275273.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Adamis Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $6.7B) with ownership activity and broader fundamentals.

Adamis Pharmaceuticals's current cash is $6.7B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.